What We're Reading
Industry reads hand-picked by our editors
Apr 07, 2026
Apr 06, 2026
Apr 03, 2026
-
Undark
Inside the Effort to Sequence a Thousand Measles Genomes
-
Stat
Small drugmakers, facing tariff threat, negotiate pricing deals with White House
-
The Financial Times
How US anti-vaxxers found they were not immune to pushback
-
The New York Times
Doctors Couldn’t Help Them. They Rolled the Dice With A.I.
Apr 02, 2026
Apr 01, 2026
-
Politico
Gilead accused of blocking global access to HIV drug
-
Reuters
British drug-cost watchdog recommends use of Novo’s Wegovy to lower heart risks
-
Fierce Biotech
KBP hopes to revive troubled heart drug at center of deal fraud dispute with Novo Nordisk
-
The New York Times
Heeding Kennedy’s Wishes, F.D.A. Is Expected to Lift Restriction on Peptides
Mar 31, 2026
Mar 30, 2026
-
The New York Times
Ozempic Is About to Go Generic for Billions of People
-
South China Morning Post
China biotech deals hit record as innovative drugs draw interest of multinationals
-
Stat
Health care giants are trimming jobs, not driving employment growth
-
Fierce Biotech
Top 10 pharma R&D budgets in 2025
